阿尔法陶医疗 DRTS
$13.72 +$0.42 (+3.16%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $14.01 +2.08%
开盘$13.51
昨收$13.30
当日区间$13.16 – $13.98
成交量418.0K
市值$1.27B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$13.78M-42.8% YoY
净利润-$45.81M-353.0% YoY
摊薄每股收益-$0.50-284.6% YoY
自由现金流-$9.12M-221.5% YoY
经营现金流-$8.74M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-141.7%
资产收益率-75.5%
投入资本回报率-119.7%
流动比率11.09
负债/资产比率67.2%
现金及投资$100.64M
总负债$13.84M
净现金（净负债）$86.80M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $13.78M | $13.31M | $42.29M | $12.60M | $10.73M |
| 销售及管理费用 | $3.88M | $2.34M | $10.22M | $3.03M | $2.42M |
| -销售及营销费用 | $311,000.00 | $241,000.00 | $1.86M | $452,000.00 | $490,000.00 |
| -管理费用 | $3.56M | $2.10M | $8.36M | $2.57M | $1.93M |
| 研发费用 | $9.91M | $10.98M | $32.07M | $9.58M | $8.31M |
| 营业利润 | -$13.78M | -$13.31M | -$42.29M | -$12.60M | -$10.73M |
| 非经营性利息净收入（支出） | $11.34M | -$9.64M | $3.42M | $4.07M | -$2.31M |
| 其他财务成本合计 | -$9.62M | $9.64M | $72,000.00 | -$577,000.00 | $617,000.00 |
| 税前利润 | -$45.58M | -$22.95M | -$42.51M | -$12.17M | -$11.69M |
| 税费 | $229,000.00 | -$11,000.00 | $121,000.00 | -$35,000.00 | -$8,000.00 |
| 净利润 | -$45.81M | -$22.94M | -$42.63M | -$12.14M | -$11.69M |
| 持续经营利润 | -$45.81M | -$22.94M | -$42.63M | -$12.14M | -$11.69M |
| 归属母公司净利润 | -$45.81M | -$22.94M | -$42.63M | -$12.14M | -$11.69M |
| 归属普通股股东净利润 | -$45.81M | -$22.94M | -$42.63M | -$12.14M | -$11.69M |
| 基本每股收益 | -$0.50 | -$0.26 | -$0.53 | -$0.14 | -$0.14 |
| 摊薄每股收益 | -$0.50 | -$0.26 | -$0.53 | -$0.14 | -$0.14 |
| 非经营性利息收入 | – | – | $3.84M | – | – |
| 非经营性利息支出 | – | – | $347,000.00 | – | – |
| 其他收入（支出） | – | – | -$3.64M | – | – |
| 证券出售收益 | – | – | -$3.64M | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $134.25M | $108.77M | $105.65M | $105.65M | $104.69M |
| 流动资产合计 | $106.83M | $81.35M | $78.30M | $78.30M | $77.10M |
| 现金及现金等价物与短期投资 | $100.64M | $76.42M | $73.13M | $73.13M | $72.21M |
| -现金及现金等价物 | $22.99M | $4.64M | $12.20M | $12.20M | $3.33M |
| -短期投资 | $77.65M | $71.78M | $60.92M | $60.92M | $68.88M |
| 应收款 | $2.06M | $1.12M | $336,000.00 | $336,000.00 | $1.22M |
| -其他应收款 | $2.06M | $1.12M | $336,000.00 | $336,000.00 | $1.22M |
| 受限现金 | $4.13M | $3.81M | $3.78M | $3.78M | $3.67M |
| 非流动资产合计 | $27.42M | $27.43M | $27.35M | $27.35M | $27.59M |
| 固定资产净值 | $26.89M | $26.96M | $26.88M | $26.88M | $27.12M |
| -固定资产原值 | $26.89M | $26.96M | $32.15M | $32.15M | $27.12M |
| 一年以上预付资产 | $525,000.00 | $462,000.00 | $479,000.00 | $479,000.00 | $472,000.00 |
| 负债合计 | $90.20M | $39.42M | $28.55M | $28.55M | $27.11M |
| 流动负债合计 | $9.63M | $10.45M | $10.51M | $10.51M | $9.14M |
| 应付款 | $8.32M | $9.25M | $3.87M | $3.87M | $8.02M |
| -应付账款 | $3.17M | $3.72M | $3.87M | $3.87M | $3.06M |
| -其他应付款 | $5.15M | $5.53M | – | – | $4.97M |
| 短期债务及融资租赁负债 | $1.32M | $1.20M | $1.13M | $1.13M | $1.12M |
| -一年内到期融资租赁负债 | $1.32M | $1.20M | $1.13M | $1.13M | $1.12M |
| 非流动负债合计 | $80.56M | $28.97M | $18.05M | $18.05M | $17.97M |
| 长期债务及融资租赁负债 | $13.84M | $13.14M | $12.60M | $12.60M | $12.38M |
| -长期债务 | $6.80M | $6.40M | $6.35M | $6.35M | $6.15M |
| -长期融资租赁负债 | $7.03M | $6.74M | $6.24M | $6.24M | $6.23M |
| 衍生产品负债 | $47.54M | $15.75M | $5.35M | $5.35M | $5.43M |
| 一年以上递延负债 | $19.19M | $85,000.00 | $97,000.00 | $97,000.00 | $151,000.00 |
| 股东权益合计 | $44.06M | $69.35M | $77.10M | $77.10M | $77.58M |
| 股东权益 | $44.06M | $69.35M | $77.10M | $77.10M | $77.58M |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $302.94M | $282.43M | $267.24M | $267.24M | $255.58M |
| 留存收益 | -$258.89M | -$213.08M | -$190.14M | -$190.14M | -$178.00M |
| 预付资产 | – | – | $1.06M | $1.06M | – |
| -累计折旧 | – | – | -$5.27M | -$5.27M | – |
| 一年内应计费用 | – | – | $3.78M | $3.78M | – |
现金流量表
| 项目 | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2022 Q2 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$26.68M | -$19.78M | -$17.96M | -$23.88M | -$8.74M |
| 持续经营经营活动现金流净额 | -$26.68M | -$19.78M | -$17.96M | -$23.88M | -$8.74M |
| 持续经营净利润 | -$42.63M | -$31.75M | -$29.16M | -$33.76M | -$2.00M |
| 持续经营损益 | $2.05M | -$259,000.00 | -$2.03M | $3.79M | – |
| 折旧、折耗与摊销 | $1.23M | $1.10M | $1.07M | $979,000.00 | $244,000.00 |
| 其他非现金项目 | -$245,000.00 | $40,000.00 | $1.74M | -$1.33M | -$17.04M |
| 营运资金变动 | $2.29M | $1.17M | $2.49M | -$307,000.00 | -$2.51M |
| -预付资产变动 | -$68,000.00 | -$519,000.00 | $201,000.00 | $1.30M | $1.02M |
| -应付账款及应计费用变动 | $1.47M | $1.62M | $2.37M | -$986,000.00 | -$3.53M |
| -其他流动资产变动 | $817,000.00 | $789,000.00 | $729,000.00 | $535,000.00 | – |
| -其他流动负债变动 | -$23,000.00 | -$726,000.00 | -$809,000.00 | -$1.15M | – |
| -其他营运资金变动 | $97,000.00 | – | – | – | – |
| 投资活动现金流净额 | -$20.59M | $20.77M | $18.68M | -$89.94M | -$92.38M |
| 持续经营投资活动现金流净额 | -$20.59M | $20.77M | $18.68M | -$89.94M | -$92.38M |
| 固定资产购置及出售净额 | -$6.08M | -$2.24M | -$6.40M | -$904,000.00 | -$377,000.00 |
| 投资购置及出售净额 | -$14.51M | $23.11M | $28.24M | -$89.03M | – |
| 筹资活动现金流 | $45.77M | $25,000.00 | $5.30M | $96.91M | $14.82M |
| 持续经营筹资活动现金流净额 | $45.77M | $25,000.00 | $5.30M | $96.91M | $14.82M |
| 债务发行及偿还净额 | $0.00 | $0.00 | $5.25M | $0.00 | – |
| 普通股发行净额 | $45.50M | $0.00 | $0.00 | – | – |
| 股票期权行使所得 | $272,000.00 | $25,000.00 | $49,000.00 | $3.36M | $1.91M |
| 期末现金余额 | $12.20M | $13.72M | $12.66M | $6.69M | $12.36M |
| 现金净变动 | -$1.50M | $1.01M | $6.02M | -$16.91M | -$86.31M |
| 期初现金余额 | $13.72M | $12.66M | $6.69M | $23.85M | $98.91M |
| 汇率变动影响 | -$21,000.00 | $57,000.00 | -$50,000.00 | -$258,000.00 | -$240,000.00 |
| 自由现金流 | -$32.76M | -$22.02M | -$24.36M | -$24.78M | -$9.12M |
| 其他投资变动净额 | – | -$103,000.00 | -$3.15M | – | – |
| 其他筹资费用净额 | – | – | – | $93.54M | $12.91M |
暂无评论——快来第一个聊聊 DRTS。
登录后参与讨论。